Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2005
03/10/2005US20050053616 peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens
03/10/2005US20050053596 Extracellular material used in formation of new bones and bone growth for repair or regeneration
03/10/2005US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
03/10/2005US20050053577 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs; for treatment of cancer
03/10/2005US20050053559 Carotenoid composition and method for protecting skin
03/10/2005US20050053558 Lemon balm, passion flower, and valerian; and the hormone melatonin
03/10/2005US20050053557 Administering a lignan comprising 4-(phenyl)-furo/3*,4*:6,7/-naphtho/2,3-d/-1,3-dioxole derivative or plant extract
03/10/2005US20050053555 Appetite control compositions and methods of use
03/10/2005US20050053554 Method for treatment of a region of the skin of a human subject, in particular cosmetic treatment by the trans-epidermal route using projection of a liquid under pressure
03/10/2005US20050053553 Combined doses of formoterol and fluticasone
03/10/2005US20050051922 Dosage form comprising: controlled release core of an antihyperglycemic drug and an excipient.seal coat applied to the controlled release core; may also include immediate release thiazolidinedione coating over the seal coat
03/10/2005US20050051483 forskolin, isoforskolin or 7-deacetylforskolin complexing/solubilizing with cyclodextrin agent; ophthamology
03/10/2005US20050050859 Low temperature methods for hermetically sealing reservoir devices
03/10/2005DE202004019875U1 Composition useful for modifying the vaginal pH of pregnant women to influence the sex of the baby has an acidic or basic pH and a defined viscosity
03/10/2005CA2765058A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
03/10/2005CA2564227A1 Novel drug compositions and dosage forms of topiramate
03/10/2005CA2546482A1 Compositions and methods for delivery of biologically active agents
03/10/2005CA2537610A1 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005CA2537413A1 Sustained release dosage forms of ziprasidone
03/10/2005CA2537184A1 Gene therapy for skin disorders using needleless syringes
03/10/2005CA2537178A1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
03/10/2005CA2536906A1 Compositions for treating pathologies that necessitate suppression of gastric acid secretion
03/10/2005CA2536902A1 Proton pump inhibitor formulations, and methods of preparing and using such formulations
03/10/2005CA2536738A1 Aerosol delivery of curcumin
03/10/2005CA2536582A1 Intranasal opioid compositions
03/10/2005CA2536507A1 Stepwise delivery of topiramate over prolonged period of time
03/10/2005CA2536466A1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
03/10/2005CA2536453A1 Use of surfactant preparations for the treatment of surgical adhesions
03/10/2005CA2536319A1 Amorphous, spray-dried powders having a reduced moisture content and a high-long term stability
03/10/2005CA2536249A1 Delivery of immune response modifier compounds
03/10/2005CA2536246A1 Skeletally targeted nanoparticles
03/10/2005CA2535923A1 Formulations and methods of treating inflammatory bowel disease
03/09/2005EP1512429A1 Needles coated with vaccine
03/09/2005EP1512410A1 Use of a composition for treating organ tissue injury caused by reperfusion of blood flow following a period of ischemia
03/09/2005EP1512405A1 Chloasma amelioration composition and dullness amelioration composition
03/09/2005EP1512403A1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
03/09/2005EP1512399A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
03/09/2005EP1512398A1 Intravascular stent with cytoskeletal inhibitors for the prevention of restenosis
03/09/2005EP1512395A1 Biodegradable macromers for the controlled release of biologically active substances
03/09/2005EP1512394A1 Universal controlled-release composition comprising chitosan
03/09/2005EP1512393A1 Process for the production of homogeneous liposomes and lipoplexes
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511811A2 Oil-soluble pigment compositions
03/09/2005EP1511790A1 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
03/09/2005EP1511580A2 Lipobeads and their production
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511514A1 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
03/09/2005EP1511495A1 Progestagenic dosage units
03/09/2005EP1511494A1 Androgen pharmaceutical composition and method for treating depression
03/09/2005EP1511490A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
03/09/2005EP1511489A1 New pharmaceutical compositions containing flibanserin polymorph a
03/09/2005EP1511487A1 Novel formulation for the parenteral application of crobenetine
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511471A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
03/09/2005EP1511470A2 A process for preparing a pharmaceutical active ingredient with high specific surface area
03/09/2005EP1511469A1 Triggered start products and processes for the production and use thereof
03/09/2005EP1511468A1 Nanoparticulate sterol formulations and sterol combinations
03/09/2005EP1511467A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
03/09/2005EP1511466A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
03/09/2005EP1511415A2 OPTICAL SAMPLING INTERFACE SYSTEM FOR i IN VIVO /i MEASUREMENT OF TISSUE
03/09/2005EP1511378A2 Antifungal parenteral products
03/09/2005EP1480985B1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
03/09/2005EP1453484A4 Methods and materials for detecting genetic material
03/09/2005EP1432407B1 Lisinopril compositions having large-particle dcpd
03/09/2005EP1401397B1 Pharmaceutical formulation having a masked taste and method for the production thereof
03/09/2005EP1303261B1 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
03/09/2005EP1255552B1 Prostaglandin compositions for the treatment for male erectile dysfunction
03/09/2005EP1239830B1 Dosage forms having a barrier layer to laser ablation
03/09/2005EP1231902B1 Film coating method for tablets
03/09/2005EP1210064B1 Thermally-activated microchip chemical delivery devices
03/09/2005EP1194154B1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon
03/09/2005EP1124536B1 Propofol composition comprising pentetate
03/09/2005EP0991408B1 Novel process for manufacturing paroxetine solid dispersions
03/09/2005EP0973504B1 Hemostatic aerosol composition
03/09/2005EP0831847B1 Method of synthesis of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions
03/09/2005EP0784481B1 Wound healing formulations containing human plasma fibronectin
03/09/2005EP0673241B1 Use of a free radical quenching liposomal composition for the manufacture of a medicament for the treatment of inflammatory conditions
03/09/2005CN2683121Y Capsule
03/09/2005CN1592753A Methods for preparing purified daptomycin
03/09/2005CN1592681A System, method and device for mfg. dosage forms
03/09/2005CN1592630A Injection solution comprising an LHRH antagonist
03/09/2005CN1592622A Orodispersible tablets containing fexofenadine
03/09/2005CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
03/09/2005CN1592613A Drug form with different shapes of cores and shells
03/09/2005CN1592612A Drug form with core and shell
03/09/2005CN1592611A Modified release dosage forms
03/09/2005CN1592610A Modified release dosage forms
03/09/2005CN1592609A Abuse-resistant opioid dosage form
03/09/2005CN1592608A Micropherules containing a pleuromutilin derivative
03/09/2005CN1592607A Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
03/09/2005CN1592606A Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules
03/09/2005CN1592602A Method for mfg.inner core
03/09/2005CN1592600A Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
03/09/2005CN1592585A Encapsulated materials
03/09/2005CN1592583A Capsule with fast content solubilization and release
03/09/2005CN1590398A Preparation of gentian effective part and its application
03/09/2005CN1589907A Controlled release medicine for ophthalmic disease
03/09/2005CN1589906A New oral formulation for 5-HT4 agonists or antagonists
03/09/2005CN1589888A Traditional Chinese medicine for SARS acute period treatment and its preparation method
03/09/2005CN1589887A Medicial composition for treating lithiasis and its preparation method
1 ... 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 ... 2991